Carl is a clinical epidemiologist and leading expert in EBM, research methods and regulatory science.
He has extensive experience in Systematic reviews and is Director of the NIHR SPCR Evidence Synthesis Working Group, and he led the Tamiflu systematic reviews.
His work includes investigating drug and devices, advising governments on regulatory evidence and healthcare projects in the public interest.